BioMedical Engineering and Imaging Institute (BMEII)
The BioMedical Engineering and Imaging Institute – BMEII (formally TMII) will develop novel medical inventions in the fields of imaging, nanomedicine, artificial intelligence, robotics, sensors, medical devices and computer vision technologies such virtual real, augmented and extended reality. BMEII provides support for all in vivo imaging research including neuroimaging, cardiovascular imaging, cancer imaging, nanomedicine (molecular imaging and drug delivery), and image processing in the preclinical and clinical settings. BMEII instrumentation and services include:
- Human Imaging (MRI, MR/PET, CT)
- Human Mock MRI
- Human and Animal Imaging Peripherals
- Human and Animal Anesthesia and Monitoring
- Large Animal Imaging (MRI, MR/PET)
- Small Animal MRI
- Small Animal PET/CT
- Small Animal Optical Imaging (Fluorescence, Bioluminescence, Near-infrared)
- Staff-Assisted Imaging
- Imaging Processing and Data Analysis
- Industry Sponsored Fees/rates – contact the BMEII Director, Zahi A. Fayad, PhD – email@example.com
- Federal/Non-Profit rates – Resource Fees
BMEII encourages study teams to reach out early on when they are assessing study feasibility, completing site selection paperwork and during the budgeting and contracting stages to ensure appropriate resources/infrastructure are available to support the study. A project consultation with the BMEII technical director must be conducted prior to budgeting, contracting and IRB submission.
New projects first require a consultation with the technical director to discuss the intended project, protocol feasibility, and any other technical or operational issues. Subsequent review and approval of a formally submitted project proposal by the Imaging Resources Management Committee (IRMC) is required. For additional information visit the BMEII Starting a Study page.
Questions – Contact Christopher.Cannistraci@mssm.edu
A signed memorandum (SOP105) from the BMEII Director is required to be included in the Internal Documents tab of the InfoEd application. Research applications with an imaging component that fail to include this memorandum will be unable to submit their applications through InfoEd.
Researchers requiring access to the MRI suites must receive MRI Safety Training.
Internal IT Systems
Black Family Stem Cell Institute
Researchers at the Black Family Stem Cell Institute advance stem cell biology by harnessing the potential embryonic, adult and induced pluripotent stem cells. This promising field presents tremendous opportunities for scientific breakthroughs that translate into medical treatments capable of replacing damaged or malignant cells with healthy stem cells, differentiated cell derivatives, or bioengineered tissues. These advances are essential for providing the foundation for regenerative therapies in diseases such as blood and cardiovascular diseases, diabetes, eye, skin and liver-related diseases, Parkinson’s and neurodegenerative diseases, and certain cancers.
- Stem Cell Engineering Core
- Derivation of induced Pluripotent Stem Cells (iPSC) from patient blood samples
- Lung and airway epithelia derived from human pluripotent stem cells for COVID-19 studies
- Directed Differentiation into specific cell types
- Genome Editing
- Training – iPSC culture techniques
- Flow Cytometry
- Mouse Genetics and Gene Targeting
The Charles Bronfman Institute for Personalized Medicine
The Charles Bronfman Institute for Personalized Medicine is driving innovation in the data-driven and gene-based individualization of health care. The Institute has led the creation of the BioMe BioBank Program to support genome-informed personalized medicine. BioMe BioBank is an electronic medical record-linked biobank which serves as a rich resource for biomedical and genetic research.
- DNA and Plasma samples
- Phenotypic data
- Genotypic data
- DNA or Plasma extraction services (for non-clinical research samples)
- Re-contacting services for prospective studies
ConduITS – The Institutes for Translational Sciences
Drug Discovery Institute
The Drug Discovery Institute is a hub for the development of new drugs that result from basic and clinical research programs throughout the Mount Sinai Healthy System. The Drug Discovery Institute provides state-of-the-art facilities, multidisciplinary expertise and services. Resources include:
- Fully equipped synthetic chemistry laboratories
- Major instrumentation such as chromatography, HPLC, NMR, LC-MS (SCB)
- Evaluation of high throughput and virtual screens
- Hit validation and follow-up
- Lead identification
- Chemical tools for in vivo studies in preclinical animal models of disease
- Lead optimization to identify candidates for clinical studies
- Design and development of projects to produce monoclonal antibodies (mAbs) with therapeutic applications
- Partnerships with Regeneron and others companies to produce humanized mAb
- CTAD has expertise in the generation of protein immunogens using a number of expression systems.
- High throughput systems for screening and analysis of antibodies
- CTAD excels in the generation of antibodies to challenging targets.
Structure Based Drug Discovery
- Computational approach to understand target structures and interactions with ligands. Access to Schrodinger platform.
- Medicinal Chemistry: an efficient, economical way to identify compounds to generate and optimize lead small molecule drugs
- Antibodies: techniques are used to map and define lead antibodies for IP filing
- Virtual Screening, Protein Structure Modeling, Ligand Binding Site Identification
- Cheminformatics, Molecular Graphics
Assay Development and Screening
Our core also provides extensive consultation and technical assistance for user-initiated and executed projects, including support for assay design, automation and data analysis.
Our integrated resources include:
- A 50k compound diverse library.
- Both human and mouse Mission siRNA/shRNA libraries from Sigma-Aldrich.
- Two automatic liquid handling systems, Janus Integrator Platform and hp D300 Dispenser, which are able to handle liquid samples from milliliters to picoliters.
- Two plate readers, FLIPRtetra plus with 384-channel head and Envision with whole sets of filters for reading different plates.
- ImageXpress Ultra system, which is able to perform medium to high throughput of high content screens.
Pluripotent Stem Cells
- Expansion of Pluripotent Stem Cell Lines
- Reprograming Fibroblasts
- Reprograming Blood Cells
- Supply Center – Provide several reagents, cytokines, cell culture media, and many more at a very competitive price.
- Shared Equipment
- Stem Cell Stock
- CRISPR Core
Institute for Health Care Delivery Science
Institute for Transformative Clinical Trials (ITCT)
The Mount Sinai Institute for Transformative Clinical Trials (ITCT) provides expertise to ISMMS investigators conducting multi-center clinical trials.
- Study Design Expertise
- Recruitment Expertise
- Regulatory Management & Compliance (including international agencies)
- Database Design & Management
- Trial Management
- Quality Assurance & Data Monitoring
- Trial Analysis
Institute for Translational Epidemiology (ITE)
The Institute for Translational Epidemiology (ITE) is committed to expanding the role of epidemiology in clinical research. ITE provides expertise and resources to support Mount Sinai researchers, through collaborations, consultations, and training courses.
- World Trade Center (WTC) Biorepository of human and animal tissue samples
- General Thoracic Surgery STS Database
- Training courses:
- Introduction to Qualitative Research Methods (Mount Sinai)
- Introduction to the Use of Healthcare Database for Population Health Research (Mount Sinai)
- Healthcare Data Science Course (University of Brescia, Italy)
- The Center for Cancer and Aging
- Center for Disaster Health, Trauma and Resilience
- Large datasets
- Epidemiological methods
- Chronic disease epidemiology
- Cancer Epidemiology
- Environmental Epidemiology
- Genetic Epidemiology
- Infectious Disease Epidemiology
- Mental Health
- Disparities Research
Microvascular Surgery Facility
The Microvasular Surgery facility, within the Translational Transplant Research Center (P. Heeger, MD, Director), offers established microsurgical procedures and techniques predominantly in mouse models of transplantation. Additional procedures can be optimized in rats as required.
- Heterotopic heart transplatation
- Kidney transplantation
- Skin grafting
- Intra ocular injection
- Renal subcapsular injections
- Catheter placement
- Coronary artery ligation
- Partial hepatectomy
- Thymectomy, splenectomy, nephrectomy
We will provide training on basic microsurgical skills and develop new surgical models as needed.
All procedures and surgical time are fee for service.
Peter Heeger, MD
Vasile Pavlov, MD
Precision Immunology Institute
The Precision Immunology Institute encompasses and integrates disease-focused immunological research programs and cutting-technology centers.
- Human Immune Monitoring Center (HIMC) combines cutting edge technology with deep immunological expertise to provide comprehensive immune monitoring for clinical and translational studies. HIMC offers:
- Study Design and Consultation
- Biospecimen Processing and Sample Management
- Soluble Factor Profiling
- Phenotypic and Functional Immune Cell Characterization
- Immunogenomics and single Cell Transriptomics
- Multiplexed Tissue Imaging
- Data Management and Analysis
- Microbiome Translational Center
The Tisch Cancer Institute
For a list of Institutes at the Icahn School of Medicine at Mount Sinai, click here.